홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
PRTC
#5778
PureTech Health plc American Depositary Shares
16.7
7
+0.72%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.72%
월간 변동
-11.69%
6달 변화
-4.17%
년간 변동율
-5.79%
이전 종가
16.6
5
Open
17.0
0
Bid
Ask
Low
16.7
7
High
17.0
0
양
2
마켓
주식
헬스케어
PRTC
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
285.89 M
287.8 M
278.57 M
271.85 M
239.42 M
1.08 B
Valuation ratios
Enterprise value
15.76 B
10.19 B
—
6.61 B
4.15 B
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0
0.07
0.05
0.1
0.05
—
Return on equity %
0.01
0.11
0.07
0.15
0.07
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
—
Operating margin %
1 015.73
864.29
1 266.53
4 390.36
2 818.87
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
38.82
360.65
237.32
2 000.84
575.43
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.29
2.22
3.99
6.76
9.33
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.02
0
0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
PureTech Health plc - American Depositary Shares
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
뉴스
듀피르페니돈, 희귀 폐 질환 치료제로 FDA 희귀의약품 지정
Deupirfenidone receives orphan drug status for rare lung disease
퓨어테크, 특발성 폐섬유증 치료제 FDA·EU 희귀의약품 지정
PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF
PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
PureTech CEO to present at J.P. Morgan Healthcare Conference
퓨어테크 헬스, 로버트 린을 정식 CEO로 임명
PureTech Health appoints Robert Lyne as permanent CEO
퓨어테크, 주주 우려에 따른 AGM 결과 업데이트
PureTech provides update on AGM results following shareholder concerns
퓨어테크, FDA 미팅 후 IPF 약물 관련 주가 하락
PureTech stock falls after FDA meeting on IPF drug